Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
Providence Medical Technology, Inc., a pioneer in less invasive solutions for spine surgery, today announced enrollment of ...
Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...
Metronidazole-Based Standard of Care with Favorable Tolerability MIAMI BEACH, Fla., March 19, 2026 /PRNewswire/ -- Crescel LLC, an innovative science and technology company, today announced results ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...
Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...
Medical Device Network on MSN
Providence Medical enrols first patients in CORUS-LX system trial
Subjects are randomised to receive posterior fusion using either the CORUS-LX system or the standard posterior fusion method.
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results